Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
LPL Financial | LPLA | 10. oct 2024 | 243.36 | -1.00 |
LQR House | LQR | 10. oct 2024 | 0.50 | +14.16 |
LSB Industries | LXU | 10. oct 2024 | 9.56 | +16.87 |
LSI Industries | LYTS | 10. oct 2024 | 16.44 | -1.02 |
Ltc Properties | LTC | 10. oct 2024 | 35.36 | -0.90 |
Lucas GC | LGCL | 10. oct 2024 | 1.16 | +3.57 |
Lucid Diagnostics | LUCD | 10. oct 2024 | 0.78 | -2.86 |
Lucid Group | LCID | 10. oct 2024 | 3.33 | -1.77 |
Lufax ADR | LU | 10. oct 2024 | 3.40 | 0.00 |
Lululemon Athletica | LULU | 10. oct 2024 | 273.58 | -0.20 |
Lulus Fashion Lounge | LVLU | 10. oct 2024 | 1.55 | -11.43 |
Lumen Technologies | LUMN | 10. oct 2024 | 6.28 | -2.33 |
Lument Finance Trust | LFT | 10. oct 2024 | 2.42 | +0.83 |
Lument Finance Trust A Pref | LFT-A | 10. oct 2024 | 22.08 | +2.65 |
Lumentum | LITE | 10. oct 2024 | 67.10 | -0.86 |
Luminar Technologies A | LAZR | 10. oct 2024 | 0.86 | -7.07 |
Lumos Pharma | LUMO | 10. oct 2024 | 3.85 | +3.58 |
Luna Innovations | LUNA | 10. oct 2024 | 1.74 | -8.66 |
Luokung Technology | LKCO | 10. oct 2024 | 2.09 | -21.14 |
Luxfer | LXFR | 10. oct 2024 | 12.74 | -2.00 |
LuxUrban Hotels | LUXH | 10. oct 2024 | 0.05 | -17.21 |
Luxurban Hotels Pref | LUXHP | 10. oct 2024 | 14.50 | -2.62 |
Lxp Industrial Trust | LXP | 10. oct 2024 | 9.49 | -1.25 |
LXP Industrial Trust C Pref | LXP-C | 10. oct 2024 | 51.54 | -2.57 |
Lyell Immunopharma | LYEL | 10. oct 2024 | 1.09 | +0.93 |
Lyft A | LYFT | 10. oct 2024 | 12.41 | -0.80 |
LyondellBasell Industries Nv A | LYB | 10. oct 2024 | 94.66 | +0.60 |
Lyra Therapeutics | LYRA | 10. oct 2024 | 0.22 | -0.22 |
Lytus Technologies | LYT | 10. oct 2024 | 1.76 | +2.92 |
M&T Bank | MTB | 10. oct 2024 | 179.08 | +0.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.